EWA
MGNX icon

EverSource Wealth Advisors’s MacroGenics MGNX Stock Holding History

EverSource Wealth Advisors’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-47
Closed -$57 – 4419
2025
Q2 		$57 Sell
47
-18
-28% -$26 ﹤0.01% 4183
2025
Q1 		$83 Buy
65
+43
+195% +$112 ﹤0.01% 3855
2024
Q4 		$72 Buy
+22
New +$79 ﹤0.01% 3595
2023
Q3 		– Sell
-10
Closed -$54 – 2601
2023
Q2 		$54 Hold
10
– – ﹤0.01% 2458
2023
Q1 		$72 Buy
+10
New +$60 ﹤0.01% 2342

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EverSource Wealth Advisors's MGNX Position: Q3 2025 in Review

EverSource Wealth Advisors sold out of MacroGenics (MGNX) in Q3 2025, closing a stake of 47 shares — an estimated $57 sold.

EverSource Wealth Advisors first reported a position in MGNX in Q1 2023 and held it in 5 quarters. The position peaked at $83 in Q1 2025. 104 funds tracked by Wall St. Rank hold MGNX as of Q3 2025.

  • EverSource Wealth Advisors reported no remaining MacroGenics position as of Q3 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 47 MacroGenics shares in Q3 2025, an estimated $57.
  • EverSource Wealth Advisors first reported a position in MacroGenics in Q1 2023 and held it in 5 quarters.
  • EverSource Wealth Advisors's MacroGenics position peaked at $83 in Q1 2025.
  • 104 funds tracked by Wall St. Rank held MacroGenics as of Q3 2025.

Based on EverSource Wealth Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.